Because of the increase in FGF21 in the CNS (Figure 1) and the previously reported correlation between higher CSF FGF21 levels and high serum FGF21 (and concomitant BMI) [50], potential target cell populations affected in ALS are also broad. The gene discussed is FGF21; the disease is amyotrophic lateral sclerosis.